(Q48025464)

7 February 2018

title

Impact of dermatologic adverse events on quality of life in 283 cancer patients: a questionnaire study in a dermatology referral clinic. (English)

1 reference

7 February 2018

0 references

1 reference

1 reference

7

1 reference

7 February 2018

Dennis West

object named as

Dennis P West

6

0 references

author name string

Alyx C Rosen

1

1 reference

7 February 2018

Emily C Case

2

1 reference

7 February 2018

Stephen W Dusza

3

1 reference

7 February 2018

Yevgeniy Balagula

4

1 reference

7 February 2018

Jennifer Gordon

5

1 reference

7 February 2018

publication date

1 August 2013

1 reference

7 February 2018

American Journal of Clinical Dermatology

published in

1 reference

7 February 2018

volume

14

1 reference

7 February 2018

issue

4

1 reference

7 February 2018

page(s)

327-333

1 reference

7 February 2018

https://scigraph.springernature.com/pub.10.1007/s40257-013-0021-0

exact match

0 references

cites work

Dermatologic manifestations of cytotoxic therapy

1 reference

https://api.crossref.org/works/10.1007%2FS40257-013-0021-0

Cutaneous side-effects of kinase inhibitors and blocking antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-013-0021-0

The risk of nail changes with epidermal growth factor receptor inhibitors: a systematic review of the literature and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-013-0021-0

Mechanisms of cutaneous toxicities to EGFR inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-013-0021-0

Search for evidence-based approaches for the prevention and palliation of hand-foot skin reaction (HFSR) caused by the multikinase inhibitors (MKIs).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-013-0021-0

Pegylated liposomal doxorubicin-associated hand-foot syndrome: recommendations of an international panel of experts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-013-0021-0

Evolving strategies for the management of hand-foot skin reaction associated with the multitargeted kinase inhibitors sorafenib and sunitinib.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-013-0021-0

Management of hand-foot syndrome induced by capecitabine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-013-0021-0

Patient versus clinician symptom reporting using the National Cancer Institute Common Terminology Criteria for Adverse Events: results of a questionnaire-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-013-0021-0

Beyond the FDA PRO guidance: steps toward integrating meaningful patient-reported outcomes into regulatory trials and US drug labels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-013-0021-0

Commentary: encouraging clinicians to incorporate longitudinal patient-reported symptoms in routine clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-013-0021-0

Skin toxicity evaluation protocol with panitumumab (STEPP), a phase II, open-label, randomized trial evaluating the impact of a pre-Emptive Skin treatment regimen on skin toxicities and quality of life in patients with metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-013-0021-0

Skin toxicities associated with epidermal growth factor receptor inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-013-0021-0

Effects of epidermal growth factor receptor inhibitor-induced dermatologic toxicities on quality of life.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-013-0021-0

Physical and psychosocial impact of acne in adult females

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-013-0021-0

Impact of sedative and non-sedative antihistamines on the impaired productivity and quality of life in patients with pruritic skin diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-013-0021-0

Unanticipated toxicities from anticancer therapies: survivors' perspectives.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-013-0021-0

Anticipating an altered appearance: women undergoing chemotherapy treatment for breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-013-0021-0

Patients report improvements in continuity of care when quality of life assessments are used routinely in oncology practice: secondary outcomes of a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-013-0021-0

10.1007/S40257-013-0021-0

21 January 2018

Identifiers

DOI

1 reference

7 February 2018

release_ydmwwx6ykjdljcmitglykcebju

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ydmwwx6ykjdljcmitglykcebju

mapped directly with Wikidata item

24 November 2022

based on heuristic

PubMed ID

23625802

1 reference

7 February 2018